Abstract
Serological antibody assays used in hepatitis C virus diagnosis have improved in sensitivity and specificity. However, detection of active viremia or monitoring levels of virus during or after patient treatment is most commonly undertaken using nucleic acid-based technologies. Advancements in diagnostic technologies and implications for managing patients with hepatitis C in various clinical settings are discussed.
MeSH terms
-
Genotype
-
Hepacivirus / genetics
-
Hepacivirus / immunology
-
Hepacivirus / isolation & purification*
-
Hepatitis C / blood
-
Hepatitis C / diagnosis*
-
Hepatitis C / genetics
-
Hepatitis C / immunology
-
Hepatitis C Antibodies / blood*
-
Humans
-
Reagent Kits, Diagnostic / trends
-
Serologic Tests / methods
-
Serologic Tests / trends*
-
Viremia / diagnosis
-
Viremia / virology
Substances
-
Hepatitis C Antibodies
-
Reagent Kits, Diagnostic